Retinoid-lipid drug carrier
Abstract:
What is described is a pharmaceutical composition for treating a fibrotic disease comprising a drug carrier, which comprises a lipid and a retinoid, and a double-stranded nucleic acid molecule, which comprises an antisense sequence to mRNA encoding human hsp47.
Public/Granted literature
Information query
Patent Agency Ranking
0/0